Developer docs
API playgroundTry for free, no card

Search company profiles

The Mood Center

Full company profile

uuid005gnr1

Namestring
The Mood Center
Legal namestring
Mood Center, LLC
Company typeenum
Private
Founded yearstring
-
Descriptiontext

The Mood Center (Mood Center, LLC) is a private mental health clinic operating two locations in Annapolis and Columbia, Maryland. The clinic specializes in interventional psychiatry treatments for treatment-resistant depression, PTSD, OCD, bipolar disorder, chronic pain, and related mood disorders. Its core service portfolio comprises three ketamine modalities—IV ketamine infusion, IM ketamine injection, and FDA-approved SPRAVATO (esketamine) nasal spray—alongside Transcranial Magnetic Stimulation (TMS) delivered via the Magstim system. Supporting services include NAD+ and Vitamin IV therapy for wellness and in-house psychiatric medication management by nurse practitioners.

The business operates on a fee-for-service clinical model with revenue drawn from insurance reimbursement (in-network with CareFirst, Anthem, Aetna, Cigna, United Healthcare, Tricare, Maryland Medicaid, and Medicare) and patient self-pay, particularly for IV ketamine and wellness IV services. Patient acquisition is driven by free consultations, an online scheduling form, referrals from psychiatrists, therapists, and primary care physicians, and listings on Psychology Today and WebMD. Treatments are administered as structured protocols—initial series followed by maintenance sessions—creating a recurring revenue cadence for SPRAVATO and TMS patients.

The Mood Center is independently owned and operated with no disclosed parent company or institutional investment. Leadership comprises Lawrence Adler (CEO), Brad Masters (CMO and Director), Adam Brown (CFO), and Libby Adler (Director). The firm maintains partnerships with advocacy and professional organizations including AFSP, Wounded Warrior Project, ASKP, and Osmind, and a service partnership with Magstim for TMS equipment. The clinic is positioned as a regional specialty provider in the Baltimore-Washington DC metro corridor rather than a multi-state or national chain.

Short descriptiontext

The Mood Center is a two-location mental health clinic in Maryland offering ketamine therapy (IV, IM, and SPRAVATO) and TMS for treatment-resistant depression, PTSD, OCD, chronic pain, and related mood disorders, serving patients across the Baltimore-Washington DC metro area.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
1–10
akta.pro rankint
HeadquartersAnnapolis , MD, United States
HQ citystring
Annapolis , MD
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices2 records

Each record includes

City, Country, Type, Description, Source

Keyword5 values
ketamine therapy, transcranial magnetic stimulation, interventional psychiatry, treatment-resistant depression, mental health clinic
Industry2 codes
PRIMARYHLAFABAC
Outpatient Mental Health & Counseling Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAFACAA
Outpatient Mental Health Clinics & Counseling Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment
NAICS code2 codes
  • Outpatient Mental Health and Substance Abuse Centers621420
  • Offices of Physicians, Mental Health Specialists621112
SIC code2 codes
  • Services-Specialty Outpatient Facilities, Nec8093
  • Services-Offices & Clinics Of Doctors Of Medicine8011
Product category
Interventional Psychiatry / Mental Health Services
GTM motion1 record

Each record includes

Type, Description, Source

Revenue model4 records
1Ketamine Therapy Services
TypeSubscription Recurring
Description

IV ketamine infusions, IM ketamine injections, and SPRAVATO (esketamine) nasal spray treatments. Revenue generated through insurance reimbursement and patient self-pay. Treatment protocols include initial series followed by maintenance sessions.

themoodcenter.com
2TMS Therapy Services
TypeSubscription Recurring
Description

Transcranial Magnetic Stimulation treatments. FDA-approved and covered by most insurance plans. Revenue from insurance reimbursement for approved clinical conditions.

themoodcenter.com
3NAD+ and Vitamin IV Therapy
TypeProfessional Services
Description

IV vitamin and NAD+ therapy services for wellness and energy support. Typically self-pay services.

themoodcenter.com
4Medication Management
TypeSubscription Recurring
Description

Psychiatric medication management services provided by nurse practitioners. Billed through insurance or self-pay.

themoodcenter.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels4 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components5 values
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure
Pricing details4 tiers
1IV Ketamine Infusion Series
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Typically a series of 6 sessions over 2-3 weeks, each session lasting 40-60 minutes. Self-pay at most clinics; pricing varies. Contact clinic for specific rates.

themoodcenter.com
2SPRAVATO (Esketamine) Treatment
ModelSubscriptionBilling cadenceMonthly
Notes

Twice-weekly sessions for first month, then weekly or biweekly maintenance. Covered by most major insurance plans including Medicare.

themoodcenter.com
3TMS Therapy
ModelSubscriptionBilling cadenceMulti-year contract
Notes

Daily sessions (5 days/week) for 6-9 weeks, each session 20-40 minutes. Covered by most insurance plans for approved conditions.

themoodcenter.com
4Free Consultation
ModelOtherBilling cadencePay-as-you-go
Notes

No-cost consultation to evaluate patient eligibility, discuss treatment options, and verify insurance benefits.

themoodcenter.com
GTM typeB2C
B2C
Offering typeServices
Services
Core offering1 text field

The Mood Center is a mental health clinic that delivers medically supervised interventional psychiatry treatments — including IV ketamine infusions, IM ketamine injections, FDA-approved SPRAVATO (esketamine) nasal spray, and Transcranial Magnetic Stimulation (TMS) via the Magstim system — for patients with treatment-resistant depression, PTSD, OCD, anxiety, bipolar disorder, chronic pain, migraines, and suicidality. The clinic operates two Maryland locations (Annapolis and Columbia), accepts most major insurance plans including Medicare and Maryland Medicaid, and complements treatments with NAD+ IV therapy, vitamin IV infusions, and psychiatric medication management.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 5 values shown
  • 50-60% response rate for TMS in treatment-resistant depression (JAMA Psychiatry 2016 meta-analysis)
+4 more records
Product overview1 text field

The Mood Center is a multi-service mental health and wellness clinic offering a suite of interventional psychiatry treatments centered around ketamine-based therapies and transcranial magnetic stimulation (TMS). The core portfolio includes three ketamine modalities — IV Ketamine Infusion Therapy, IM Ketamine Injections, and SPRAVATO (esketamine) Nasal Spray — which are used to treat treatment-resistant depression, PTSD, OCD, anxiety, bipolar disorder, chronic pain, migraines, addiction, and suicidality. The TMS Therapy offering (using the Magstim system) complements the ketamine portfolio for patients who need or prefer a non-medication, non-invasive option. Supporting services include NAD+ IV Therapy, Vitamin IV Therapy for wellness, and in-house Medication Management. The clinic operates out of two Maryland locations (Annapolis and Columbia) and accepts a broad range of insurance plans including CareFirst, Anthem, Aetna, Cigna, UnitedHealthcare, Tricare, Maryland Medicaid, and Medicare.

Product and service7 records
1IV Ketamine Therapy
CategoryInterventional Psychiatry — Ketamine Therapy
Description

Medically supervised intravenous ketamine infusion therapy designed to create new healthy brain pathways (Network Reconfiguration), used to treat treatment-resistant depression, mood disorders, chronic pain, migraines, PTSD, OCD, anxiety, bipolar disorder, suicidality, postpartum depression, and addiction. Treatment typically involves a series of 6 sessions over 2–3 weeks, with each session lasting 40–60 minutes.

2IM Ketamine Injections
CategoryInterventional Psychiatry — Ketamine Therapy
Description

Intramuscular ketamine injection therapy delivering rapid symptom relief for mood disorders, chronic pain, and treatment-resistant depression. Administered in a controlled, professional environment by trained clinicians.

3SPRAVATO (Esketamine) Nasal Spray Treatment
CategoryInterventional Psychiatry — Ketamine Therapy
Description

FDA-approved esketamine nasal spray therapy for patients with depression who have tried at least two other antidepressants without remission or at least 50% improvement. Administered in-clinic under medical monitoring, with twice-weekly sessions in the first month followed by weekly or biweekly maintenance.

4Transcranial Magnetic Stimulation (TMS) Therapy
CategoryInterventional Psychiatry — TMS
Description

Non-invasive, FDA-approved brain stimulation therapy using the Magstim system. Targeted magnetic pulses induce electric currents at specific brain regions affected by mood disorders. FDA-approved for depression and OCD, with evidence supporting use in anxiety and PTSD. Administered daily (5 days/week) for 6–9 weeks, with each session lasting 20–40 minutes, supervised by psychiatric nurse practitioners with specialized training in interventional psychiatry.

5NAD+ IV Therapy
CategoryWellness IV Therapy
Description

Intravenous NAD+ (nicotinamide adenine dinucleotide) therapy delivered alongside other IV treatments to support cellular health, energy, and overall wellness. Typically a self-pay service.

6Vitamin IV Therapy
CategoryWellness IV Therapy
Description

Vitamin IV therapy delivering essential nutrients and hydration directly into the bloodstream for immune support, energy enhancement, anti-aging, and wellness purposes. Self-pay service.

7Psychiatric Medication Management
CategoryPsychiatric Services — Medication Management
Description

Ongoing psychiatric medication management provided by psychiatric nurse practitioners to support and maintain treatment gains from ketamine and TMS therapies, coordinate with outside therapists, and monitor patient progress over time. Billed through insurance or self-pay.

Scale indicator1 record

Each record includes

Type, Value, Description, Source

Partnership7 partners
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Mental health technology platform partner providing practice management and patient tracking tools. Listed as member/supporter of the Osmind community.

Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed provider directory on Psychology Today, one of the largest mental health referral platforms. Increases visibility to patients searching for mental health providers.

Strategic tierMinorTypeGTM or Marketing Partner
Description

Supporter/member of AFSP, demonstrating commitment to suicide prevention efforts and alignment with mental health advocacy mission.

4ASKP (American Society of Ketamine Physicians)
Strategic tierMinorTypeStrategic or Co-development Partner
Description

Member/supporter of professional organization dedicated to advancing ketamine therapy practice standards and education.

themoodcenter.com
Strategic tierMinorTypeGTM or Marketing Partner
Description

Partner organization supporting veterans with mental health needs. The Mood Center provides specialized services for veterans near Fort Meade.

6WebMD
Strategic tierMinorTypeChannel Partner/ Reseller/ Distributor
Description

Listed as a partner/supporter on WebMD, increasing visibility and credibility among health-conscious consumers seeking treatment information.

themoodcenter.com
7Magstim
Strategic tierCoreTypeTechnology or Integration
Description

Equipment provider for TMS therapy using the Magstim TMS system - a clinically validated platform with established evidence base. Core technology partnership for delivering TMS treatments.

themoodcenter.com
Recent move6 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeDirect peer
Description

Multi-state ketamine and TMS clinic chain offering interventional psychiatry for treatment-resistant depression; directly comparable service stack and outpatient clinic model, with broader geographic reach than The Mood Center.

TypeBroad incumbent
Description

Established multi-clinic psychiatric practice offering brain imaging, medication management, and TMS for mood and cognitive disorders; broader psychiatric portfolio but directly overlaps with The Mood Center on TMS for treatment-resistant depression in an outpatient setting.

3Joyous
TypeEmerging player
Description

Direct-to-consumer telehealth ketamine provider offering at-home microdose ketamine for depression and anxiety; competes for the same self-pay, treatment-resistant patient pool as The Mood Center but through a remote, lower-cost delivery model.

TypeBroad incumbent
Description

National TMS-focused clinic network providing transcranial magnetic stimulation for depression and OCD across 70+ U.S. locations; overlapping core service line (TMS) and treatment-resistant patient population, though does not offer ketamine therapies.

TypeDirect peer
Description

Multi-location ketamine infusion clinics targeting treatment-resistant depression, PTSD, and anxiety; operates an outpatient clinic model directly comparable to The Mood Center, with in-clinic IV ketamine as the core offering.

TypeDirect peer
Description

Pioneering outpatient ketamine clinic group offering IV/IM ketamine and SPRAVATO for mood and chronic pain disorders; directly comparable in clinical scope and in-clinic delivery model, though serving a different metro.

TypeDirect peer
Description

Direct competitor in ketamine therapy for treatment-resistant depression and anxiety; Mindbloom delivers at-home sublingual ketamine via telehealth, whereas The Mood Center delivers in-clinic IV/IM/SPRAVATO. Both target the same patient use cases through different delivery models.

8Field Trip Health (now Enthea)
TypeDirect peer
Description

Former multi-location ketamine-assisted psychotherapy clinic chain (now restructured as Enthea); historically directly comparable in offering in-clinic ketamine plus psychedelic therapies for depression, anxiety, and PTSD in major North American metros.

TypeEmerging player
Description

Multi-state ketamine and TMS clinic operator offering interventional psychiatry for treatment-resistant depression; comparable service stack and insurance-based model, with overlap in target patient demographic.

TypeEmerging player
Description

Outpatient interventional psychiatry practice offering ketamine and SPRAVATO for treatment-resistant depression; directly comparable in clinical scope and private-pay/insurance reimbursement model, though operates in different geographies.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment7 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile6 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature5 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles6 records

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
No data
Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

The Mood Center

Interventional Psychiatry / Mental Health Servicesthemoodcenter.com

The Mood Center is a two-location mental health clinic in Maryland offering ketamine therapy (IV, IM, and SPRAVATO) and TMS for treatment-resistant depression, PTSD, OCD, chronic pain, and related mood disorders, serving patients across the Baltimore-Washington DC metro area.

What The Mood Center does

The Mood Center (Mood Center, LLC) is a private mental health clinic operating two locations in Annapolis and Columbia, Maryland. The clinic specializes in interventional psychiatry treatments for treatment-resistant depression, PTSD, OCD, bipolar disorder, chronic pain, and related mood disorders. Its core service portfolio comprises three ketamine modalities—IV ketamine infusion, IM ketamine injection, and FDA-approved SPRAVATO (esketamine) nasal spray—alongside Transcranial Magnetic Stimulation (TMS) delivered via the Magstim system. Supporting services include NAD+ and Vitamin IV therapy for wellness and in-house psychiatric medication management by nurse practitioners.

The business operates on a fee-for-service clinical model with revenue drawn from insurance reimbursement (in-network with CareFirst, Anthem, Aetna, Cigna, United Healthcare, Tricare, Maryland Medicaid, and Medicare) and patient self-pay, particularly for IV ketamine and wellness IV services. Patient acquisition is driven by free consultations, an online scheduling form, referrals from psychiatrists, therapists, and primary care physicians, and listings on Psychology Today and WebMD. Treatments are administered as structured protocols—initial series followed by maintenance sessions—creating a recurring revenue cadence for SPRAVATO and TMS patients.

The Mood Center is independently owned and operated with no disclosed parent company or institutional investment. Leadership comprises Lawrence Adler (CEO), Brad Masters (CMO and Director), Adam Brown (CFO), and Libby Adler (Director). The firm maintains partnerships with advocacy and professional organizations including AFSP, Wounded Warrior Project, ASKP, and Osmind, and a service partnership with Magstim for TMS equipment. The clinic is positioned as a regional specialty provider in the Baltimore-Washington DC metro corridor rather than a multi-state or national chain.

The Mood Center firmographics

Firmographics
Name
The Mood Center
Legal name
Mood Center, LLC
Website
https://themoodcenter.com
Company type
Private
Operating status
Operating
Headcount range
1–10 employees
Short description
The Mood Center is a two-location mental health clinic in Maryland offering ketamine therapy (IV, IM, and SPRAVATO) and TMS for treatment-resistant depression, PTSD, OCD, chronic pain, and related mood disorders, serving patients across the Baltimore-Washington DC metro area.
Ownership category
akta.pro rank

The Mood Center industry classification

Industry
Product category
Interventional Psychiatry / Mental Health Services
NAICS
Outpatient Mental Health and Substance Abuse Centers (621420), Offices of Physicians, Mental Health Specialists (621112)
SIC
Services-Specialty Outpatient Facilities, Nec (8093), Services-Offices & Clinics Of Doctors Of Medicine (8011)
akta.pro industry
PRIMARYHLAFABAC
Outpatient Mental Health & Counseling Clinics
Healthcare & Life Sciences/Healthcare Providers & Systems/Ambulatory & Outpatient Care Centers
SECONDARYHLAFACAA
Outpatient Mental Health Clinics & Counseling Centers
Healthcare & Life Sciences/Healthcare Providers & Systems/Behavioral Health & Substance Use Treatment

Keywords

  • Ketamine therapy
  • Transcranial magnetic stimulation
  • Interventional psychiatry
  • Treatment-resistant depression
  • Mental health clinic

Where The Mood Center is headquartered

Location

Headquarters

HQ city
Annapolis , MD
HQ country
United States
HQ region
North America

Offices2 records

Markets served

The Mood Center business model

Business model
GTM type
B2C
Offering type
Services
Cost components
Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

  1. Ketamine Therapy Services: IV ketamine infusions, IM ketamine injections, and SPRAVATO (esketamine) nasal spray treatments. Revenue generated through insurance reimbursement and patient self-pay. Treatment protocols include initial series followed by maintenance sessions.
  2. TMS Therapy Services: Transcranial Magnetic Stimulation treatments. FDA-approved and covered by most insurance plans. Revenue from insurance reimbursement for approved clinical conditions.
  3. NAD+ and Vitamin IV Therapy: IV vitamin and NAD+ therapy services for wellness and energy support. Typically self-pay services.
  4. Medication Management: Psychiatric medication management services provided by nurse practitioners. Billed through insurance or self-pay.

Pricing tiers

ModelBillingPrice
SubscriptionMulti-year contractIV Ketamine Infusion Series
SubscriptionMonthlySPRAVATO (Esketamine) Treatment
SubscriptionMulti-year contractTMS Therapy
OtherPay-as-you-goFree Consultation

Go-to-market motion1 record

Distribution channels4 records

Marketing channels5 records

The Mood Center product offering

Product offering

Core offering

The Mood Center is a mental health clinic that delivers medically supervised interventional psychiatry treatments — including IV ketamine infusions, IM ketamine injections, FDA-approved SPRAVATO (esketamine) nasal spray, and Transcranial Magnetic Stimulation (TMS) via the Magstim system — for patients with treatment-resistant depression, PTSD, OCD, anxiety, bipolar disorder, chronic pain, migraines, and suicidality. The clinic operates two Maryland locations (Annapolis and Columbia), accepts most major insurance plans including Medicare and Maryland Medicaid, and complements treatments with NAD+ IV therapy, vitamin IV infusions, and psychiatric medication management.

Product overview

The Mood Center is a multi-service mental health and wellness clinic offering a suite of interventional psychiatry treatments centered around ketamine-based therapies and transcranial magnetic stimulation (TMS). The core portfolio includes three ketamine modalities — IV Ketamine Infusion Therapy, IM Ketamine Injections, and SPRAVATO (esketamine) Nasal Spray — which are used to treat treatment-resistant depression, PTSD, OCD, anxiety, bipolar disorder, chronic pain, migraines, addiction, and suicidality. The TMS Therapy offering (using the Magstim system) complements the ketamine portfolio for patients who need or prefer a non-medication, non-invasive option. Supporting services include NAD+ IV Therapy, Vitamin IV Therapy for wellness, and in-house Medication Management. The clinic operates out of two Maryland locations (Annapolis and Columbia) and accepts a broad range of insurance plans including CareFirst, Anthem, Aetna, Cigna, UnitedHealthcare, Tricare, Maryland Medicaid, and Medicare.

Differentiator

Problem solved

Functional benefit

Products and services

  • IV Ketamine Therapy Medically supervised intravenous ketamine infusion therapy designed to create new healthy brain pathways (Network Reconfiguration), used to treat treatment-resistant depression, mood disorders, chronic pain, migraines, PTSD, OCD, anxiety, bipolar disorder, suicidality, postpartum depression, and addiction. Treatment typically involves a series of 6 sessions over 2–3 weeks, with each session lasting 40–60 minutes.
  • IM Ketamine Injections Intramuscular ketamine injection therapy delivering rapid symptom relief for mood disorders, chronic pain, and treatment-resistant depression. Administered in a controlled, professional environment by trained clinicians.
  • SPRAVATO (Esketamine) Nasal Spray Treatment FDA-approved esketamine nasal spray therapy for patients with depression who have tried at least two other antidepressants without remission or at least 50% improvement. Administered in-clinic under medical monitoring, with twice-weekly sessions in the first month followed by weekly or biweekly maintenance.
  • Transcranial Magnetic Stimulation (TMS) Therapy Non-invasive, FDA-approved brain stimulation therapy using the Magstim system. Targeted magnetic pulses induce electric currents at specific brain regions affected by mood disorders. FDA-approved for depression and OCD, with evidence supporting use in anxiety and PTSD. Administered daily (5 days/week) for 6–9 weeks, with each session lasting 20–40 minutes, supervised by psychiatric nurse practitioners with specialized training in interventional psychiatry.
  • NAD+ IV Therapy Intravenous NAD+ (nicotinamide adenine dinucleotide) therapy delivered alongside other IV treatments to support cellular health, energy, and overall wellness. Typically a self-pay service.
  • Vitamin IV Therapy Vitamin IV therapy delivering essential nutrients and hydration directly into the bloodstream for immune support, energy enhancement, anti-aging, and wellness purposes. Self-pay service.
  • Psychiatric Medication Management Ongoing psychiatric medication management provided by psychiatric nurse practitioners to support and maintain treatment gains from ketamine and TMS therapies, coordinate with outside therapists, and monitor patient progress over time. Billed through insurance or self-pay.

Quantifiable outcome

  • 50-60% response rate for TMS in treatment-resistant depression (JAMA Psychiatry 2016 meta-analysis)
  • +4 more outcomes

Companies that use The Mood Center

Customer profile

Named customers6 records

Segments7 records

Ideal customer profiles6 records

The Mood Center technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature5 records

The Mood Center partnerships and signals

Strategic signal

Partnerships

Seven partnerships are on record, tiered minor and core.

  • OsmindminorStrategic or Co-development PartnerMental health technology platform partner providing practice management and patient tracking tools. Listed as member/supporter of the Osmind community.
  • Psychology TodayminorChannel Partner/ Reseller/ DistributorListed provider directory on Psychology Today, one of the largest mental health referral platforms. Increases visibility to patients searching for mental health providers.
  • American Foundation for Suicide Prevention (AFSP)minorGTM or Marketing PartnerSupporter/member of AFSP, demonstrating commitment to suicide prevention efforts and alignment with mental health advocacy mission.
  • ASKP (American Society of Ketamine Physicians)minorStrategic or Co-development PartnerMember/supporter of professional organization dedicated to advancing ketamine therapy practice standards and education.
  • Wounded Warrior ProjectminorGTM or Marketing PartnerPartner organization supporting veterans with mental health needs. The Mood Center provides specialized services for veterans near Fort Meade.
  • WebMDminorChannel Partner/ Reseller/ DistributorListed as a partner/supporter on WebMD, increasing visibility and credibility among health-conscious consumers seeking treatment information.
  • MagstimcoreTechnology or IntegrationEquipment provider for TMS therapy using the Magstim TMS system - a clinically validated platform with established evidence base. Core technology partnership for delivering TMS treatments.

Scale indicators1 record

Recent moves6 records

Expansion highlights5 records

The Mood Center competitors and assessment

Company assessment

Direct peers

  • Klarity Clinic: Multi-state ketamine and TMS clinic chain offering interventional psychiatry for treatment-resistant depression; directly comparable service stack and outpatient clinic model, with broader geographic reach than The Mood Center.
  • Pasithea Clinics: Multi-location ketamine infusion clinics targeting treatment-resistant depression, PTSD, and anxiety; operates an outpatient clinic model directly comparable to The Mood Center, with in-clinic IV ketamine as the core offering.
  • Ketamine Clinics Los Angeles (KCLA): Pioneering outpatient ketamine clinic group offering IV/IM ketamine and SPRAVATO for mood and chronic pain disorders; directly comparable in clinical scope and in-clinic delivery model, though serving a different metro.
  • Mindbloom: Direct competitor in ketamine therapy for treatment-resistant depression and anxiety; Mindbloom delivers at-home sublingual ketamine via telehealth, whereas The Mood Center delivers in-clinic IV/IM/SPRAVATO. Both target the same patient use cases through different delivery models.
  • Field Trip Health (now Enthea): Former multi-location ketamine-assisted psychotherapy clinic chain (now restructured as Enthea); historically directly comparable in offering in-clinic ketamine plus psychedelic therapies for depression, anxiety, and PTSD in major North American metros.

Broad incumbents

  • Amen Clinics: Established multi-clinic psychiatric practice offering brain imaging, medication management, and TMS for mood and cognitive disorders; broader psychiatric portfolio but directly overlaps with The Mood Center on TMS for treatment-resistant depression in an outpatient setting.
  • Greenbrook TMS: National TMS-focused clinic network providing transcranial magnetic stimulation for depression and OCD across 70+ U.S. locations; overlapping core service line (TMS) and treatment-resistant patient population, though does not offer ketamine therapies.

Emerging players

  • Joyous: Direct-to-consumer telehealth ketamine provider offering at-home microdose ketamine for depression and anxiety; competes for the same self-pay, treatment-resistant patient pool as The Mood Center but through a remote, lower-cost delivery model.
  • Healent Health: Multi-state ketamine and TMS clinic operator offering interventional psychiatry for treatment-resistant depression; comparable service stack and insurance-based model, with overlap in target patient demographic.
  • Psychiatry Redefined: Outpatient interventional psychiatry practice offering ketamine and SPRAVATO for treatment-resistant depression; directly comparable in clinical scope and private-pay/insurance reimbursement model, though operates in different geographies.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

The Mood Center social profiles

Digital presence

The Mood Center financial estimates

Financial estimate

Revenue estimate

Valuation estimate

The Mood Center leadership team

Management profile

Number of profiles

Profiles6 records

The Mood Center funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

The Mood Center M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about The Mood Center

What does The Mood Center do?

The Mood Center is a mental health clinic that delivers medically supervised interventional psychiatry treatments — including IV ketamine infusions, IM ketamine injections, FDA-approved SPRAVATO (esketamine) nasal spray, and Transcranial Magnetic Stimulation (TMS) via the Magstim system — for patients with treatment-resistant depression, PTSD, OCD, anxiety, bipolar disorder, chronic pain, migraines, and suicidality. The clinic operates two Maryland locations (Annapolis and Columbia), accepts most major insurance plans including Medicare and Maryland Medicaid, and complements treatments with NAD+ IV therapy, vitamin IV infusions, and psychiatric medication management.

Is The Mood Center a public or private company?

The Mood Center is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was The Mood Center founded?

The Mood Center was founded in -1. It employs 1 to 10 people.

Where is The Mood Center based?

The Mood Center is headquartered in Annapolis , MD, United States, in the North America region.

How does The Mood Center make money?

Four revenue lines are on record. Ketamine Therapy Services are the primary driver. The others are TMS Therapy Services, NAD+ and Vitamin IV Therapy and medication Management.

Who are The Mood Center's main competitors?

Direct peers on record are Klarity Clinic, Pasithea Clinics, Ketamine Clinics Los Angeles (KCLA), Mindbloom and Field Trip Health (now Enthea). Broad incumbents are Amen Clinics and Greenbrook TMS. Emerging players are Joyous, Healent Health and Psychiatry Redefined.

Does The Mood Center have an API?

No public API is recorded for The Mood Center.

What industry is The Mood Center in?

The Mood Center's product category is Interventional Psychiatry / Mental Health Services. Its primary akta.pro industry code is HLAFABAC, Outpatient Mental Health & Counseling Clinics, with a secondary code of HLAFACAA, Outpatient Mental Health Clinics & Counseling Centers. Its NAICS code is 621420 and its SIC code is 8093.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales